LGM
Logos Global Management’s Repare Therapeutics RPTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-600,000
| Closed | -$4.38M | – | 62 |
|
|
2023
Q4 | $4.38M | Buy |
600,000
+300,000
| +100% | +$2.19M | 0.41% | 37 |
|
|
2023
Q3 | $3.62M | Buy |
+300,000
| New | +$3.62M | 0.48% | 41 |
|
|
2022
Q1 | – | Sell |
-1,700,000
| Closed | -$35.9M | – | 62 |
|
|
2021
Q4 | $35.9M | Buy |
1,700,000
+1,680,000
| +8,400% | +$35.4M | 3.7% | 12 |
|
|
2021
Q3 | $525K | Sell |
20,000
-310,000
| -94% | -$8.14M | 0.04% | 55 |
|
|
2021
Q2 | $10.3M | Sell |
330,000
-570,000
| -63% | -$17.8M | 0.86% | 36 |
|
|
2021
Q1 | $27.6M | Buy |
900,000
+223,106
| +33% | +$6.85M | 2.7% | 10 |
|
|
2020
Q4 | $23.2M | Sell |
676,894
-300,000
| -31% | -$10.3M | 1.99% | 9 |
|
|
2020
Q3 | $30.1M | Buy |
976,894
+310,000
| +46% | +$9.54M | 3.85% | 9 |
|
|
2020
Q2 | $20.3M | Buy |
+666,894
| New | +$20.3M | 4.05% | 5 |
|